Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2024)

Eledon Pharmaceuticals' (ELDN) quarterly Interest & Investment Income came in at $102000.0 in Q3 2024, up 292.31% on a QoQ basis from $26000.0 in Q1 2017.

Analysis

Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2024) Analysis & Trends

Eledon Pharmaceuticals (ELDN) has 5 years of Interest & Investment Income data on file, last reported at $102000.0 in Q3 2024.

  • Quarterly Interest & Investment Income changed N/A year-over-year to $102000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $189000.0 (changed N/A YoY) and the FY2025 annual result came in at -$2000.0, changed N/A from the prior year.
  • Interest & Investment Income advanced to $102000.0 in Q3 2024, from $26000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $102000.0 in Q3 2024 to a low of $102000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 102,000.00
Mar 31, 2017 26,000.00
Dec 31, 2016 23,000.00
Sep 30, 2016 38,000.00
Jun 30, 2016 49,000.00
Mar 31, 2016 54,000.00
Dec 31, 2015 55,000.00
Sep 30, 2015 54,000.00
Jun 30, 2015 25,000.00
Mar 31, 2015 40,000.00
Dec 31, 2014 53,000.00
Sep 30, 2014 34,000.00
Jun 30, 2014 34,000.00
Mar 31, 2014 45,000.00